ADELLE TROUT: Open Payments
NPI 1407344476 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 25 payments from 13 companies in 2025. Trend: 2023 $125 · 2024 $119 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Vertical Pharmaceuticals, LLC | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $31 |
| Sage Therapeutics, LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Corium, LLC | 1 | $21 |
Products named: TRINTELLIX, Auvelity, CAPLYTA, Jornay PM, REXULTI, Relexxii, FANAPT, ZURZUVAE.
Industry payments across DE — which companies pay providers there.
